A Study of ICT-121 Dendritic Cell Vaccine in Recurrent Glioblastoma
NCT02049489
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
20
Enrollment
INDUSTRY
Sponsor class
Conditions
Glioblastoma Multiforme
Interventions
BIOLOGICAL:
ICT-121 DC vaccine
Sponsor
Precision Life Sciences Group